Afya (NASDAQ:AFYA) CEO Virgilio Deloy Capobian Gibbon Sells 3,900 Shares of Stock

Afya Limited (NASDAQ:AFYA) CEO Virgilio Deloy Capobian Gibbon sold 3,900 shares of the firm’s stock in a transaction that occurred on Wednesday, March 25th. The stock was sold at an average price of $15.18, for a total transaction of $59,202.00. Following the completion of the transaction, the chief executive officer directly owned 154,548 shares in the company, valued at approximately $2,346,038.64. The trade was a 2.46% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Virgilio Deloy Capobian Gibbon also recently made the following trade(s):

• On Thursday, March 26th, Virgilio Deloy Capobian Gibbon sold 800 shares of Afya stock. The shares were sold at an average price of $15.21, for a total transaction of $12,168.00.

Afya Stock Down 1.3%

AFYA opened at $14.75 on Friday. The firm’s 50 day simple moving average is $14.39 and its two-hundred day simple moving average is $14.74. The company has a market capitalization of $1.38 billion, a PE ratio of 10.10, a PEG ratio of 0.66 and a beta of 0.52. Afya Limited has a 1-year low of $13.00 and a 1-year high of $19.90. The company has a current ratio of 2.20, a quick ratio of 0.98 and a debt-to-equity ratio of 0.21.

Afya (NASDAQ:AFYA) last issued its quarterly earnings data on Wednesday, March 11th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.36 by $0.05. Afya had a net margin of 20.31% and a return on equity of 18.77%. The firm had revenue of $147.08 million during the quarter, compared to the consensus estimate of $174.74 million. As a group, equities analysts forecast that Afya Limited will post 1.52 EPS for the current year.

Afya Dividend Announcement

The business also recently declared an annual dividend, which will be paid on Monday, April 6th. Shareholders of record on Wednesday, March 25th will be given a $0.656 dividend. The ex-dividend date is Wednesday, March 25th. This represents a yield of 433.0%. Afya’s dividend payout ratio is presently 45.21%.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on AFYA shares. UBS Group reaffirmed a “neutral” rating and set a $16.00 price objective (down from $18.00) on shares of Afya in a research report on Friday, January 16th. Zacks Research raised shares of Afya from a “strong sell” rating to a “hold” rating in a report on Monday, March 9th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $22.00 price target (down from $24.50) on shares of Afya in a report on Wednesday, January 7th. Bank of America lowered shares of Afya from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $22.00 to $17.00 in a research report on Tuesday, February 24th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Afya in a research note on Wednesday, January 21st. One research analyst has rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $17.30.

Institutional Trading of Afya

Institutional investors have recently made changes to their positions in the business. Goldman Sachs Group Inc. raised its stake in Afya by 167.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 45,093 shares of the company’s stock valued at $809,000 after purchasing an additional 28,226 shares during the period. Geode Capital Management LLC boosted its stake in Afya by 85.1% in the 2nd quarter. Geode Capital Management LLC now owns 52,111 shares of the company’s stock worth $931,000 after purchasing an additional 23,961 shares during the period. Quadrature Capital Ltd purchased a new stake in Afya during the 2nd quarter valued at approximately $181,000. Quantbot Technologies LP purchased a new stake in Afya during the 2nd quarter valued at approximately $117,000. Finally, Arrowstreet Capital Limited Partnership raised its position in shares of Afya by 5.6% during the second quarter. Arrowstreet Capital Limited Partnership now owns 68,169 shares of the company’s stock valued at $1,217,000 after buying an additional 3,626 shares during the last quarter. Hedge funds and other institutional investors own 88.02% of the company’s stock.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.